Lumbar Medial Branch Blocks for Facet Joint Pain
(OMEGA Trial)
Trial Summary
What is the purpose of this trial?
This trial studies how a nerve-numbing injection in the lower back helps reduce chronic pain. It focuses on patients with ongoing low back pain and examines how well this treatment works by blocking pain signals.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those who have started new pain or psychiatric treatments within 2 weeks of enrollment. This might suggest that changes in medication close to the trial start are not allowed.
What data supports the effectiveness of the treatment Lumbar Medial Branch Blocks for Facet Joint Pain?
Research shows that cryoanalgesia, a technique used in this treatment, is effective for long-term pain relief by freezing nerves, which has been successfully applied to various types of pain, including low back pain related to lumbar facet joint issues. Additionally, ultrasound-guided lumbar facet nerve blocks have been shown to be accurate, which can improve the precision and effectiveness of the treatment.12345
Is lumbar medial branch block for facet joint pain safe for humans?
The research does not provide specific safety data for lumbar medial branch blocks, but it does mention that lidocaine, used in similar procedures, can cause changes in sensation without significant adverse effects. This suggests that similar treatments may be generally safe, but specific safety data for lumbar medial branch blocks is not available in the provided studies.678910
How is the lumbar medial branch block treatment for facet joint pain different from other treatments?
Lumbar medial branch blocks are unique because they specifically target the nerves that supply the facet joints, using a precise ultrasound-guided technique to diagnose and potentially treat facet joint pain. This method is different from other treatments as it focuses on blocking nerve signals to relieve pain, and the use of ultrasound guidance can improve accuracy and reduce the need for multiple needle placements.45111213
Research Team
Benedict J Alter, MD, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults over 18 with chronic low back pain daily for at least 3 months, who are scheduled for a lumbar medial branch block (MBB) at UPMC Pain Management clinics. Participants must be able to understand English, complete questionnaires, and handle study-related phone calls. Those with past spine surgery at the MBB level or active compensation claims can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Quantitative Sensory Testing
Participants undergo quantitative sensory testing to measure CNS pain modulation before the lumbar medial branch block
Treatment
Participants receive a lumbar medial branch block as part of routine clinical care
Follow-up
Participants report low back pain intensity in a pain diary and are monitored for changes in pain perception
Treatment Details
Interventions
- Computer Tasks (Behavioral Intervention)
- Cutaneous Probe (Behavioral Intervention)
- Quantitative Sensory Testing (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
David Apelian
University of Pittsburgh
Chief Executive Officer since 2019
PhD in Molecular Biology from Rutgers University, MD from the University of Medicine and Dentistry of New Jersey, MBA from Quinnipiac University
Pamela D. Garzone
University of Pittsburgh
Chief Medical Officer
PhD in Clinical Science from the University of Pittsburgh